Cover Image
市場調查報告書

神經義肢的全球市場(產品種·技術·用途·各地區) - 市場規模,佔有率,全球趨勢,企業簡介,需求,考察,分析,調查,報告,機會,市場區隔及預測

Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

出版商 Allied Market Research 商品編碼 320778
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經義肢的全球市場(產品種·技術·用途·各地區) - 市場規模,佔有率,全球趨勢,企業簡介,需求,考察,分析,調查,報告,機會,市場區隔及預測 Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
出版日期: 2014年11月14日 內容資訊: 英文 156 Pages
簡介

神經義肢也稱之為神經、腦移植,由於其有希望恢復傳統治療法不可能修復的受損後知覺、運動、認知機能,而在過去數年大幅興起。為了回復並提升患者生活品質,該技術的研究開發集合了官民雙方面的投資,在全球市場在今後數年預測將以15.8%的年複合成長率發展,到2020年達到140億美金的規模。

本報告以神經功能替代的全球市場為焦點,依產品種,技術,用途,地區別分析·預測交易規模的轉變,更彙整市場發展的推動·阻礙因素,研究開發,競爭環境,主要加入企業等相關的最新資訊。

第1章 簡介

  • 報告內容
  • 報告的主要優點
  • 主要市場區隔
  • 報告的推薦用戶層
  • 調查方法
    • 二次資訊調查
    • 一次資訊採訪
    • 分析工具及模式

第2章 摘要整理

  • 市場預測(單位:100萬美元)
    • 穩定成長方案
    • 急速成長方案
    • 減速成長方案

第3章 市場概要

  • 市場定義和範圍
  • 可底定的市場發展
  • 倫理的考察
  • 重要發現
    • 神經功能替代技術的主要影響係數
    • 有力資金來源
    • 成功的重要策略
  • 神經移植發展史
    • 定位固定移植
      • 歷史觀點
      • 目前趨勢
      • 競爭情形
    • 電生理學製圖
      • 歷史觀點
      • 目前趨勢
      • 競爭情形
  • 行政府法規
    • 美國的醫療設備規定
    • 歐洲的醫療設備規定
    • 亞太地區的醫療設備規定
    • 各地區法規當局隨時間變化的核準架構
  • 專利分析
    • 各地區專利分析
    • 各疾病狀況專利分析
  • 神經功能替代臨床實驗
  • 價值鏈分析
    • 腦機器介面和神經刺激設備
    • 內建式人工神經設備·移植
  • 市場佔有率分析
  • 市場動態
    • 推動要素
      • 技術的急速發展 - 有助於神經功能替代技術的提升
      • 新銳設備的認證 - 透過早期商業化確立競爭力
      • 成為神經刺激治療對象的神經疾病壓力
      • 資金及研究津貼的存在
    • 阻礙因素
      • 報酬問題 - 神經義肢普及率帶來的負面影響
      • 副作用 - 增大致死風險,導致使用率降低的要素
      • 高額的產品和治療費用
    • 機會
      • 藉由將開發階段產品早期商業來化增加競爭力

第4章 神經義肢的全球市場 - 各技術(單位:100萬美元)

  • 腦深部刺激法(DBS)
    • 歷史觀點
    • 目前趨勢
    • 競爭情形
  • 迷走神經刺激法(VNS)
  • 脊髓電刺激法(SCS)
  • 薦骨神經(SNS)

第5章 神經義肢的全球市場 - 不同形態(單位:100萬美元)

  • 運動補綴
  • 聽覺補綴·人工電子耳
  • 視覺補綴·視網膜移植
  • 知覺補綴

第6章 神經義肢的全球市場 - 各用途(單位:100萬美元)

  • 運動神經障礙
    • 帕金森氏症
    • 癲癇
  • 生理障礙
    • 聽覺障礙
    • 眼科障礙
    • 心臟障礙
    • 腎臟障礙
  • 認知障礙
    • 老年癡呆症
    • 憂鬱症

第7章 神經義肢的全球市場 - 各地區(單位:100萬美元)

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 企業簡介(企業概要,短評,業務部門,收益,策略性動向及發展,SWOT分析)

  • Boston Scientific Corporation
  • Cochlear Limited
  • Cyberonics Inc.
  • Medtronic Inc.
  • NDI Medical LLC
  • Nervo Corp.
  • NeuroPace Inc.
  • Retina Implant AG
  • ST. Jude Medical
  • Sonova Group (Advanced Bionics AG)
目錄
Product Code: ME 14580

Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the 'quality-of-life' of the affected patient populace. The Neuroprosthetics, as therapeutic modalities, are emerging as a promising option in cases where all conventional treatments fail to deliver results/treatment to the disease condition. Improvement in the 'quality-of-life' of the affected patients, high availability of funds for R&D of Neuroprosthetics from the Government (public) and private sector investments in turn aid development of newer and improved variants of Neuroprosthetics - all result in increased uptake by the patients. Thus, the afore-mentioned are key drivers of the Neuroprosthetics market; however, reimbursement issues and high cost of Neuroprosthetics/devices are the restraints to the market growth. Owing to the high-impact growth drivers that outweigh the restraints, the global neuroprosthetics market is forecast to reach $14 billion by 2020, registering a CAGR of 15.8% from 2014 to 2020.

The global neuroprosthetics market is segmented based on technology, types, applications and geography. The Neuroprosthetics' Mechanism Of Action (MOA) varies as per underlying technology; hence, Neuroprosthetics can also be classified by technology into - Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS) and Sacral Nerve Stimulation (SCS). Various types of Neuroprosthetics have been developed based on the application areas, i.e., the disease condition treated, for example, Motor Neuroprosthetics - treat motor neuron disorders such as Parkinson's disease, Epilepsy, Auditory Neuroprosthetics/ Cochlear implants - treat hearing disorders; Visual Neuroprosthetics/ Retinal implants - treat visual impairment; and Cognitive Neuroprosthetics - treat Alzheimer's disease, and severe depression. Visual Neuroprosthetics/ Retinal implants, is the fastest growing (CAGR 31.5%) Neuroprosthetics segment, owing to high-impact growth attribute of improving 'quality-of-life' of visually impaired patients. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.

Developing bio-compatible, sensitive and safe products are the keys to success in the global Neuroprosthetics market. In tune with this, many companies across the world are involved in the R&D of newer and multitude of variants of Neuroprosthetics' product lines and is seeking regulatory approval and commercialization. Few of such companies are profiled in the report - Medtronic Inc., MED-EL, Advanced Bionics AG, Boston Scientific Corporation, Biomet, Inc., St. Jude Medical, Retina Implant AG, NeuroPace, Inc. and NDI Medical LLC.

KEY BENEFITS

  • An in-depth analysis of the current Neuroprosthetics market scenario, future market estimates and trend-analysis - to reveal holistic picture that in turn facilitates decision making
  • Quantitative analysis of the current market and estimations through 2013-2020 - to assist corporate strategists to design business strategies to capitalize on the current and future (possible) opportunities in the market
  • Strategic analysis of key market players and business strategies within the global Neuroprosthetics market provided - would assist stakeholders to make informed business decisions
  • Pinpoint intelligence of key investment pockets are illustrated from the manufacturers point of view
  • Report emphasizes on the key strategies adopted by the giants operating in the neuroprosthetic devices market
  • Technological trends of neurological devices are critically analyzed and validated through primaries
  • Identification of key product segments based on current and potential growth prospects - to reveal most profitable segments that can be catered to by the market players

MARKET SEGMENTATION

The global neuroprosthetics market is segmented according to / by - technology, type, application, and geography.

MARKET BY TECHNOLOGY

  • Deep Brain Simulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Spinal Cord Stimulation (SCS)
  • Sacral Nerve Stimulation (SNS)

MARKET BY TYPE

  • Motor Neuroprosthetics
  • Auditory Neuroprosthetics/ Cochlear implants
  • Visual Neuroprosthetics/ Retinal implants
  • Cognitive Neuroprosthetics

MARKET BY APPLICATION

  • Motor Neuron disorders
  • Parkinson's disease
  • Epilepsy
  • Physiological disorders
  • Auditory disorders
  • Ophthalmic disorders
  • Neurocardiac disorders
  • Over Active Bladder syndrome (kidney disorders)
  • Cognitive disorders
  • Alzheimer's disease
  • Severe depression

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1 Report Description
  • 1.2 Key Benefits
  • 1.3 Key Market Segments
  • 1.4 Key Audiences
  • 1.5 Research Methodology
    • 1.5.1 Primary Research
    • 1.5.2 Secondary Research
    • 1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1 Market beyond what to expect by 2025 ($Million)
    • 2.1.1 Moderate growth scenario
    • 2.1.2 Rapid growth scenario
    • 2.1.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

  • 3.1 Market Definition and Scope
  • 3.2 Addressable Market Scenario
  • 3.3 Ethical Considerations
  • 3.4 Key Findings
    • 3.4.1 Top Factors Impacting on global neuroprosthetics market
    • 3.4.2 Top Investment Pockets of global neuroprosthetics market
    • 3.4.3 Top winning strategies of global neuroprosthetics market
  • 3.5 Advances in neuroprosthetic implantation
    • 3.5.1 Stereotactic implantation
      • 3.5.1.1 Historical Perspective
      • 3.5.1.2 Current Trends
        • 3.5.1.2.1 INCREASING USE OF MRI, CT SCANS AND OTHER IMAGE GUIDING SYSTEMS FOR STEREOTACTIC IMPLANTATION
        • 3.5.1.2.2 ROBOTS FOR IMPROVED STEREOTAXIC PRECISION
      • 3.5.1.3 Competitive scenario
    • 3.5.2 Electrophysiological mapping
      • 3.5.2.1 Historical Perspective
      • 3.5.2.2 Current Trends
        • 3.5.2.2.1 EVOKED POTENTIAL MONITORING
        • 3.5.2.2.2 SINGLE-UNIT RECORDINGS
      • 3.5.2.3 Competitive scenario
  • 3.6 Government Regulations
    • 3.6.1 Medical Devices regulations in United States (U.S.)
    • 3.6.2 Medical Devices regulations in Europe and UK
    • 3.6.3 Medical Devices regulations in Asia-Pacific
    • 3.6.4 Regulatory approval timeframe in different regions
  • 3.7 Patent Analysis
    • 3.7.1 Patent analysis by geographies (2010-2014)
    • 3.7.2 Patent analysis based on medical condition (2011-2014)
  • 3.8 Clinical Trials for Neuroprosthetics
  • 3.9 Value chain analysis
    • 3.9.1 Brain Machine interfaces and neurostimulators
    • 3.9.2 Embedded neuroprosthetic devices/implants
  • 3.10 Market Share Analysis
  • 3.11 Market Dynamics
    • 3.11.1 Drivers
      • 3.11.1.1 Rapid progression of technology - assist in improving neuroprosthetics
      • 3.11.1.2 New device approvals- leading towards early commercialization to achieve competitive edge
      • 3.11.1.3 Rising burden of neurological disorders that responds to neurostimulation
      • 3.11.1.4 Availability of Funds and research grants
    • 3.11.2 Restraints
      • 3.11.2.1 Reimbursement Issues - have negative impact on neuroprosthetics adoption rate
      • 3.11.2.2 Adverse reactions- increases risk of mortality and decreases usage rate
      • 3.11.2.3 High cost of product and therapy
    • 3.11.3 Opportunities
      • 3.11.3.1 Early commercialization of pipeline products assists to gain competitive advantage

CHAPTER 4 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013-2020, $MILLION

  • 4.1 Deep Brain Simulation (DBS)
    • 4.1.1 Historical Perspective
    • 4.1.2 Current Trends
      • 4.1.2.1 Advancement in component system
      • 4.1.2.2 Other technological advances
    • 4.1.3 Competitive Scenario
  • 4.2 Vagus Nerve Stimulation (VNS)
    • 4.2.1 Historical Perspective
    • 4.2.2 Current trends
      • 4.2.2.1 Direct and transcutaneous vagus nerve stimulators are gaining popularity
    • 4.2.3 Competitive Scenario
  • 4.3 Spinal Cord Stimulation (SCS)
    • 4.3.1 Historical Perspective
    • 4.3.2 Current trends
      • 4.3.2.1 Rechargeable neurostimulation system gaining significant attention
        • 4.3.2.1.1 RESTORE™ RECHARGEABLE NEUROSTIMULATION SYSTEM
        • 4.3.2.1.2 EON™ NEUROSTIMULATION SYSTEM
        • 4.3.2.1.3 PRECISION™ SPINAL CORD STIMULATION SYSTEM
    • 4.3.3 Competitive Scenario
  • 4.4 Sacral Nerve Stimulation (SNS)
    • 4.4.1 Historical Perspective
    • 4.4.2 Current trends

CHAPTER 5 GLOBAL NEUROPROSTHETICS MARKET BY TYPE, 2013-2020, $MILLION

  • 5.1 Motor Prosthetics
    • 5.1.1 Key Market Trends
    • 5.1.2 Key growth factors and opportunities
    • 5.1.3 Market Size and forecast
  • 5.2 Auditory Prosthetics / Cochlear Implants
    • 5.2.1 Key Market Trends
    • 5.2.2 Key growth factors and opportunities
    • 5.2.3 Market Size and forecast
  • 5.3 Visual Prosthetics / Retinal Implants
    • 5.3.1 Key Market Trends
    • 5.3.2 Key growth factors and opportunities
    • 5.3.3 Market Size and forecast
  • 5.4 Cognitive Prosthetics
    • 5.4.1 Key Market Trends
    • 5.4.2 Key growth factors and opportunities
    • 5.4.3 Market Size and forecast

CHAPTER 6 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013-2020, $MILLION

  • 6.1 Motor Neuron disorders
    • 6.1.1 Parkinson's disease
    • 6.1.2 Epilepsy
  • 6.2 Physiological disorders
    • 6.2.1 Auditory disorders
    • 6.2.2 Ophthalmic disorders
    • 6.2.3 Cardiac disorders
    • 6.2.4 Kidney disorders
  • 6.3 Cognitive disorders
    • 6.3.1 Alzheimer's disease
    • 6.3.2 Severe depression

CHAPTER 7 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013-2020, $MILLION

  • 7.1 North America
    • 7.1.1 Key market trends
    • 7.1.2 Competitive scenario
    • 7.1.3 Key growth factors and opportunities
    • 7.1.4 Market size and forecast
  • 7.2 Europe
    • 7.2.1 Key market trends
    • 7.2.2 Competitive scenario
    • 7.2.3 Key growth factors and opportunities
    • 7.2.4 Market size and forecast
  • 7.3 Asia-Pacific
    • 7.3.1 Key market trends
    • 7.3.2 Competitive scenario
    • 7.3.3 Key growth factors and opportunities
    • 7.3.4 Market size and forecast
  • 7.4 LAMEA
    • 7.4.1 Key market trends
    • 7.4.2 Competitive scenario
    • 7.4.3 Key growth factors and opportunities
    • 7.4.4 Market size and forecast

CHAPTER 8 COMPANY PROFILES

  • 8.1 Boston Scientific Corporation
    • 8.1.1 Overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating Business Segments
    • 8.1.4 Financial performance
    • 8.1.5 Strategic moves and developments
    • 8.1.6 SWOT analysis
  • 8.2 Cochlear Limited
    • 8.2.1 Overview
    • 8.2.2 Company snapshots
    • 8.2.3 Operating Business Segments
    • 8.2.4 Financial performance
    • 8.2.5 Strategic moves and developments
    • 8.2.6 SWOT analysis
  • 8.3 Cyberonics Inc.
    • 8.3.1 Overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating Business Segments
    • 8.3.4 Financial performance
    • 8.3.5 Strategic moves and developments
    • 8.3.6 SWOT analysis
  • 8.4 Medtronic Inc.
    • 8.4.1 Company overview
    • 8.4.2 Company snapshots
    • 8.4.3 Operating Business Segments
    • 8.4.1 Financial performance
    • 8.4.2 Strategic moves and developments
    • 8.4.3 SWOT Analysis
  • 8.5 NDI Medical LLC
    • 8.5.1 Overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating Business Segments
    • 8.5.4 Strategic moves and developments
    • 8.5.5 SWOT analysis
  • 8.6 Nervo Corp.
    • 8.6.1 Overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating Business Segments
    • 8.6.4 Strategic moves and developments
    • 8.6.5 SWOT analysis
  • 8.7 NeuroPace Inc.
    • 8.7.1 Overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating Business Segments
    • 8.7.4 Strategic moves and developments
    • 8.7.5 SWOT analysis
  • 8.8 Retina Implant AG
    • 8.8.1 Overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating Business Segments
    • 8.8.4 Strategic moves and developments
    • 8.8.5 SWOT analysis
  • 8.9 ST. Jude Medical
    • 8.9.1 Overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating Business Segments
    • 8.9.4 Financial performance
    • 8.9.5 Strategic moves and developments
    • 8.9.6 SWOT analysis
  • 8.10 Sonova Group (Advanced Bionics AG)
    • 8.10.1 Company overview
    • 8.10.2 Company snapshots
    • 8.10.3 Operating Business Segments
    • 8.10.4 Financial performance
    • 8.10.5 Strategic moves and developments
    • 8.10.6 SWOT analysis

List of Tables

  • TABLE 1 MODERATE GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020 - 2025, ($MILLION)
  • TABLE 2 RAPID GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020 - 2025, ($MILLION)
  • TABLE 3 DIMINISHING GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020 - 2025, ($MILLION)
  • TABLE 4 MEDICAL DEVICE CATEGORIES LISTED BY EC
  • TABLE 1 PATENT ANALYSIS BY GEOGRAPHIES (2011-2014)
  • TABLE 2 CLINICAL TRIALS FOR NEUROPROSTHETICS
  • TABLE 3 CURRENT RESEARCH IN EMERGING TECHNOLOGIES AND THEIR APPLICATIONS IN NEUROPROSTHETICS
  • TABLE 4 LIST OF USFDA APPROVED, COMMERCIALLY AVAILABLE NEUROPROSTHETICS
  • TABLE 5 GLOBAL PREVALENCE OF NEUROLOGICAL DISORDERS
  • TABLE 6 AVERAGE COST OF NEUROPROSTHETIC THERAPY/ PRODUCTS
  • TABLE 7 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013 - 2020 ($MILLION)
  • TABLE 8 FDA APPROVED APPLICATIONS FOR DEEP BRAIN STIMULATION
  • TABLE 9 VAGUS NERVE STIMULATION DEVICE: FACT SHEET
  • TABLE 10 GLOBAL NEUROPROSTHETICS MARKET BY TYPES, 2013 - 2020 ($MILLION)
  • TABLE 11 COMPANIES AND THEIR FDA APPROVED COCHLEAR IMPLANTS
  • TABLE 12 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
  • TABLE 13 PARKINSON'S DISEASE NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 14 EPILEPSY NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 15 GLOBAL ESTIMATE AND PREVALENCE OF DISABLING HEARING LOSS, IN ADULTS 15 YEARS OR OLDER AND CHILDREN 0-14 YEARS (MILLIONS AND PERCENTAGE OF POPULATION)
  • TABLE 16 AUDITORY DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 17 OPHTHALMIC DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 18 NEUROCARDIAC DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 19 KIDNEY DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 20 ALZHEIMEER'S DISEASE NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 21 SEVERE DEPRESSION NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 22 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 23 NORTH AMERICA NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 24 EUROPE NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 25 ASIA-PACIFIC NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 26 LAMEA NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 27 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
  • TABLE 28 BOSTON SCIENTIFIC CORPORATION OPERATING SEGMENTS
  • TABLE 29 COCHLEAR CORPORATION SNAPSHOT
  • TABLE 30 COCHLEAR CORPORATION OPERATING SEGMENTS
  • TABLE 31 CYBERONICS INC SNAPSHOT
  • TABLE 32 MEDTRONIC SNAPSHOT
  • TABLE 33 MEDTRONIC OPERATING SEGMENTS
  • TABLE 34 NDI MEDICAL SNAPSHOT
  • TABLE 35 NDI MEDICAL LLC OPERATING SEGMENTS
  • TABLE 36 NERVO CORP. SNAPSHOT
  • TABLE 37 NEUROPACE INC. SNAPSHOT
  • TABLE 38 RETINA IMPLANT AG SNAPSHOT
  • TABLE 39 ST. JUDE MEDICAL SNAPSHOT
  • TABLE 40 ST. JUDE MEDICAL OPERATING SEGMENTS
  • TABLE 41 SONOVA GROUP SNAPSHOT
  • TABLE 42 SONOVA GROUP OPERATING SEGMENTS

List of Figures

1 TOP FACTORS IMPACTING NEUROPROSTHETICS MARKET (2013-2020)

  • FIG. 2 TOP INVESTMENT POCKETS OF GLOBAL NEUROPROSTHETICS MARKET(2013)
  • FIG. 3 TOP WINING STRATEGIES FOR GLOBAL NEUROPROSTHETICS MARKET (2011-2014)
  • FIG. 4 STRATEGIC SHARE OF NEUROPROSTHETICS APPLICATION
  • FIG. 5 TOP WINING STRATEGIES BY NEUROPROSTHETICS APPLICATION
  • FIG. 6 FDA APPROVED INDICATIONS FOR NEUROPROSTHETICS
  • FIG. 7 AVERAGE APPROVAL TIME FOR DIFFERENT CLASSES OF MEDICAL DEVICE IN LEADING MARKETS IN 2013
  • FIG. 8 PATENT ANALYSIS BY GEOGRAPHIES (2011-2014)
  • FIG. 9 PATENT ANALYSIS BASED ON MEDICAL CONDITION(2011-2014)
  • FIG. 10 NEUROPROSTHETICS- VALUE CHAIN
  • FIG. 11 GLOBAL NEUROPROSTHETICS MARKET SHARE ANALYSIS (2013)
  • FIG. 12 GLOBAL MOTOR PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 13 GLOBAL AUDITORY PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 14 GLOBAL VISUAL PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 15 GLOBAL COGNITIVE PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 16 PREVALENCE OF ALZHEIMER'S DISEASE IN UNITED STATES, BY AGE (2014)
  • FIG. 17 REVENUE OF BOSTON SCIENTIFIC CORPORATION. BY GEOGRAPHY(2013)
  • FIG. 18 REVENUE BOSTON SCIENTIFIC CORPORATION. BY PRODUCT GROUPS(2013)
  • FIG. 19 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION.
  • FIG. 20 REVENUE OF COCHLEAR CORPORATION LTD. BY GEOGRAPHY(2014)
  • FIG. 21 REVENUE OF COCHLEAR CORPORATION LTD. BY PRODUCT GROUPS(2014)
  • FIG. 22 SWOT ANALYSIS OF MEDTRONIC INC.
  • FIG. 23 REVENUE OF CYBERONICS INC. BY GEOGRAPHY(2014)
  • FIG. 24 SWOT ANALYSIS OF CYBERONICS INC.
  • FIG. 25 REVENUE OF MEDTRONIC INC. BY GEOGRAPHY(2013)
  • FIG. 26 REVENUE MEDTRONIC INC. BY BUSINESS GROUP(2013)
  • FIG. 27 SWOT ANALYSIS OF MEDTRONIC INC.
  • FIG. 28 SWOT ANALYSIS OF NDI MEDICAL LLC.
  • FIG. 29 SWOT ANALYSIS OF NERVO CORP.
  • FIG. 30 SWOT ANALYSIS OF NEUROPACE INC.
  • FIG. 31 SWOT ANALYSIS OF NEUROPACE INC.
  • FIG. 32 NET SALES OF ST. JUDE MEDICAL. BY GEOGRAPHY(2013)
  • FIG. 33 NET SALES OF ST. JUDE MEDICAL. BY BUSINESS GROUP(2013)
  • FIG. 34 SWOT ANALYSIS OF ST. JUDE MEDICAL.
  • FIG. 35 REVENUE OF SONOVA GROUP. BY GEOGRAPHY(2013/14)
  • FIG. 36 REVENUE SONOVA GROUP. BY PRODUCT GROUPS(2013/14)
  • FIG. 37 SWOT ANALYSIS OF SONOVA HOLDING AG.
Back to Top